Analyst Ratings for Neurocrine Bio. (NBIX)
NBIX Rating Summary
NBIX Price Target Summary
- Highest: $253.00 (Citi)
- Lowest: $150.00 (BMO Capital)
- Average: $199.96
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$199.96 (+47.3%)
* Over Last 12-Mos
Rating Score: 8.4 / 10
Percentile Rank: 86%
Avg. $ Target:
$199.96 (+47.3%)
* Over Last 12-Mos
Rating Score: 8.4 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2026 | Guggenheim | Delma Caiati | New Coverage | Buy (N/A) |
207.00 (N/A) |
143.18 (135.71) |
-5.22% | Details |
| 9/18/2026 | CCB Int'l | N/A | New Coverage | Outperform (N/A) |
N/A (N/A) |
151.83 (135.71) |
-10.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
